Yayın:
Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSazan Haji Ali
dc.contributor.authorDerya Osmani̇ye
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.orcid0000-0002-5960-8067
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2026-05-20T09:42:03Z
dc.date.issued2025-01-01
dc.identifier.doi10.1039/d5ra05755h
dc.identifier.endpage45743
dc.identifier.issn2046-2069
dc.identifier.issue53
dc.identifier.openalexW4416492049
dc.identifier.startpage45729
dc.identifier.urihttps://hdl.handle.net/11421/38610
dc.identifier.urihttps://doi.org/10.1039/d5ra05755h
dc.identifier.volume15
dc.language.isoen
dc.relation.ispartofRSC Advances
dc.rightsopenAccess
dc.subjectAcetylcholinesterase
dc.subjectButyrylcholinesterase
dc.subjectCytotoxicity
dc.subjectBiological activity
dc.subjectDocking (animal)
dc.subjectEnzyme
dc.subjectActive site
dc.subjectHydrazone
dc.subjectCholinesterase
dc.subjectEnzyme inhibition
dc.titleSynthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications